Investor Home

Our History

We were founded in May 2012 in Leiden the Netherlands with the goal of developing a treatment for cystic fibrosis (CF). The founding team - Daniel de Boer, Gerard Platenburg, Dinko Valerio and Henri Termeer - pulled together a team of motivated RNA and CF experts to work on a unique RNA therapy for CF. Our innovative and promising technology was licensed from Massachu  Read more

Share Performance

IR Contacts

Daniel de Boer
Chief Executive Officer
ProQR Therapeutics N.V.
Phone: +31 88 166 7000
E-mail: info@proqr.com
 
Sariette Witte
Investor Relations
Phone: +31 629 704 513
Phone: +1 213 261 8891
E-mail: ir@proqr.com